Relevance of tumor boards for the inclusion of patients in oncological clinical trials
Abstract Introduction Major national and international oncological societies generally recommend treating a significant proportion of oncological patients in clinical trials to improve therapy strategies for cancer patients. At cancer centers, the recommendation about the appropriate therapy for the...
Saved in:
Main Authors: | Hendrik Dapper, Maurice Dantes, Peter Herschbach, Hana Algül, Volker Heinemann |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2023-03-01
|
Series: | Journal of Cancer Research and Clinical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1007/s00432-022-04559-0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Relevance of tumor boards for the inclusion of patients in oncological clinical trials
by: Hendrik Dapper, et al.
Published: (2025-01-01) -
Empowering personalized oncology: evolution of digital support and visualization tools for molecular tumor boards
by: Cosima Strantz, et al.
Published: (2025-01-01) -
Benchmarking LLM chatbots’ oncological knowledge with the Turkish Society of Medical Oncology’s annual board examination questions
by: Efe Cem Erdat, et al.
Published: (2025-02-01) -
Expert Consensus on Molecular Tumor Boards in Taiwan: Joint Position Paper by the Taiwan Oncology Society and the Taiwan Society of Pathology
by: Ming-Huang Chen, et al.
Published: (2024-01-01) -
Enhancing Multidisciplinary Team Board Efficiency and Communication Using the SBAR Approach
by: Nazeer Ahmed, et al.
Published: (2025-01-01)